So what’s the catch?
For one, iPSCs can take months to make and the process is expensive. Furthermore, reverting cells back to a stem cell state wipes out their history, which is sometimes useful for studying disease progression.
In essence, iPSCs are the middlemen between one cell type and another. What if we could simply take out the middleman altogether?
Read more
Comments are closed.